Trials / Completed
CompletedNCT00614848
The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions
Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,200 (actual)
- Sponsor
- Medtronic Vascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate the safety and efficacy of the Driver Coronary Stent coated with 10 mcg/mm ABT-578 compared to the uncoated Driver Stent for the treatment of single de novo lesions in native coronary arteries 2.25-3.5 mm in diameter.
Conditions
- Coronary Artery Disease
- Arterial Occlusive Diseases
- Coronary Disease
- Coronary Arteriosclerosis
- Heart Diseases
- Myocardial Ischemia
- Vascular Diseases
- Ischemia
- Arteriosclerosis
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endeavor drug eluting coronary stent | Zotarolimus coated coronary stent (10ug/mm) |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2005-01-01
- Completion
- 2009-07-01
- First posted
- 2008-02-13
- Last updated
- 2011-04-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00614848. Inclusion in this directory is not an endorsement.